{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:29:23Z","timestamp":1789626563326,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.4158\/ep12057.or","type":"journal-article","created":{"date-parts":[[2012,7,11]],"date-time":"2012-07-11T21:05:28Z","timestamp":1342040728000},"page":"855-863","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Effect of Dexamethasone on Glucose Homeostasis In Normal and Prediabetic Subjects With A First-Degree Relative With Type 2 Diabetes Mellitus"],"prefix":"10.1016","volume":"18","author":[{"given":"Nader","family":"Taheri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf","family":"Aminorroaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faramarz","family":"Ismail-Beigi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massoud","family":"Amini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP12057.OR_bb0010","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.2337\/diacare.21.9.1414","article-title":"Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections","volume":"21","author":"King","year":"1998","journal-title":"Diabetes Care"},{"key":"10.4158\/EP12057.OR_bb0015","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.2337\/diacare.27.10.2568","article-title":"Global prevalence of diabetes: estimates for the year 2000 and projections for 2030","volume":"27","author":"Rathmann","year":"2004","journal-title":"Diabetes Care"},{"key":"10.4158\/EP12057.OR_bb0020","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/414782a","article-title":"Global and societal implications of the diabetes epidemic","volume":"414","author":"Zimmet","year":"2001","journal-title":"Nature"},{"key":"10.4158\/EP12057.OR_bb0025","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"10.4158\/EP12057.OR_bb0030","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","article-title":"Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance","volume":"344","author":"Tuomilehto","year":"2001","journal-title":"N Engl J Med"},{"key":"10.4158\/EP12057.OR_bb0035","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ecl.2003.12.006","article-title":"Prediabetes: prediction and prevention trials","volume":"33","author":"Vendrame","year":"2004","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.4158\/EP12057.OR_bb0040","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1007\/s001250051516","article-title":"Prediction of diabetes using ADA or WHO criteria in post-menopausal women: a 10-year follow-up study","volume":"43","author":"Larsson","year":"2000","journal-title":"Diabetologia"},{"key":"10.4158\/EP12057.OR_bb0045","first-page":"1","article-title":"Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose","volume":"128","author":"Santaguida","year":"2005","journal-title":"Evid Rep Technol Assess (Summ)"},{"key":"10.4158\/EP12057.OR_bb0050","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2337\/diacare.22.3.399","article-title":"Impaired fasting glucose or impaired glucose tolerance: what best predicts future diabetes in Mauritius?","volume":"22","author":"Shaw","year":"1999","journal-title":"Diabetes Care"},{"key":"10.4158\/EP12057.OR_bb0055","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2337\/dc08-1264","article-title":"Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes: results from the Botnia Study","volume":"32","author":"Abdul-Ghani","year":"2009","journal-title":"Diabetes Care"},{"key":"10.4158\/EP12057.OR_bb0060","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1046\/j.1464-5491.2002.00835.x","article-title":"Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention","volume":"19","author":"Unwin","year":"2002","journal-title":"Diabet Med"},{"key":"10.4158\/EP12057.OR_bb0065","doi-asserted-by":"crossref","first-page":"296","DOI":"10.2337\/diab.3.4.296","article-title":"An approach to the prediction of diabetes mellitus by modification of the glucose tolerance test with cortisone","volume":"3","author":"Fajans","year":"1954","journal-title":"Diabetes"},{"key":"10.4158\/EP12057.OR_bb0070","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/j.1463-1326.2011.01432.x","article-title":"Short-term metabolic effects of prednisone administration in healthy subjects","volume":"13","author":"Kauh","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"10.4158\/EP12057.OR_bb0075","doi-asserted-by":"crossref","first-page":"6035","DOI":"10.1073\/pnas.89.13.6035","article-title":"The diabetogenic effects of glucocorticoids are more pronounced in low- than in high-insulin responders","volume":"89","author":"Wajngot","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.4158\/EP12057.OR_bb0080","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/oby.2003.90","article-title":"Metabolic adaptations to dexamethasone-induced insulin resistance in healthy volunteers","volume":"11","author":"Nicod","year":"2003","journal-title":"Obes Res"},{"key":"10.4158\/EP12057.OR_bb0085","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1172\/JCI111141","article-title":"An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects","volume":"72","author":"Pagano","year":"1983","journal-title":"J Clin Invest"},{"key":"10.4158\/EP12057.OR_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/diab.19.1.1","article-title":"Levels of plasma insulin during cortisone glucose tolerance tests in \"nondiabetic\" relatives of diabetic patients: implications of diminished insulin secretory reserve in subclinical diabetes","volume":"19","author":"Rull","year":"1970","journal-title":"Diabetes"},{"key":"10.4158\/EP12057.OR_bb0095","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1007\/s001250051251","article-title":"Insulin resistant subjects lack islet adaptation to short-term dexamethasone-induced reduction in insulin sensitivity","volume":"42","author":"Larsson","year":"1999","journal-title":"Diabetologia"},{"key":"10.4158\/EP12057.OR_bb0100","doi-asserted-by":"crossref","first-page":"770","DOI":"10.4158\/EP09373.OR","article-title":"Effect of dexamethasone on oral glucose tolerance in healthy adults","volume":"16","author":"Abdelmannan","year":"2010","journal-title":"Endocr Pract"},{"issue":"suppl 1","key":"10.4158\/EP12057.OR_bb0105","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.2337\/diacare.28.suppl_1.S4","article-title":"Standards of medical care in diabetes [published correction appears in 28:990]. Diabetes Care. 2005","volume":"28","author":"American Diabetes Association","year":"2005","journal-title":"Diabetes Care."},{"key":"10.4158\/EP12057.OR_bb0110","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.disamonth.2006.03.001","article-title":"Metabolic syndrome and prediabetes","volume":"52","author":"Babu","year":"2006","journal-title":"Dis Mon"},{"key":"10.4158\/EP12057.OR_bb0115","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.2337\/diacare.25.10.1891","article-title":"A new index of insulin sensitivity obtained from the oral glucose tolerance test applicable to advanced type 2 diabetes","volume":"25","author":"Kanauchi","year":"2002","journal-title":"Diabetes Care"},{"key":"10.4158\/EP12057.OR_bb0120","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.2337\/diacare.27.6.1439","article-title":"Impaired insulin sensitivity, insulin secretion, and glucose effectiveness predict future development of impaired glucose tolerance and type 2 diabetes in pre-diabetic African Americans: implications for primary diabetes prevention","volume":"27","author":"Osei","year":"2004","journal-title":"Diabetes Care"},{"key":"10.4158\/EP12057.OR_bb0125","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"10.4158\/EP12057.OR_bb0130","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.2337\/diacare.27.9.2204","article-title":"Contribution of insulin-stimulated glucose uptake and basal hepatic insulin sensitivity to surrogate measures of insulin sensitivity","volume":"27","author":"Tripathy","year":"2004","journal-title":"Diabetes Care"},{"key":"10.4158\/EP12057.OR_bb0135","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00125-009-1614-2","article-title":"Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) study","volume":"53","author":"DeFronzo","year":"2010","journal-title":"Diabetologia"},{"key":"10.4158\/EP12057.OR_bb0140","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1210\/jc.2011-0246","article-title":"Preservation of \u03b2-cell function: the key to diabetes prevention","volume":"96","author":"DeFronzo","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP12057.OR_bb0145","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1046\/j.1365-2362.32.s3.5.x","article-title":"The evolution of beta-cell dysfunction and insulin resistance in type 2 diabetes","volume":"32","author":"Bergman","year":"2002","journal-title":"Eur J Clin Invest"},{"key":"10.4158\/EP12057.OR_bb0150","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s001250050847","article-title":"Risk and mechanism of dexamethasone-induced deterioration of glucose tolerance in non-diabetic first-degree relatives of NIDDM patients","volume":"40","author":"Henriksen","year":"1997","journal-title":"Diabetologia"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20430113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20430113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/N206V7N6272313R8.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:54:14Z","timestamp":1761515654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20430113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S1530891X20430113"],"URL":"https:\/\/doi.org\/10.4158\/ep12057.or","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Dexamethasone on Glucose Homeostasis In Normal and Prediabetic Subjects With A First-Degree Relative With Type 2 Diabetes Mellitus","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP12057.OR","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}